Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R HALL

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Cancers|April 3, 2021
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural MesotheliomaHaitang Yang, Sean R R Hall, Beibei Sun, et al.
European Urology|November 24, 1999
Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder. European Bropirimine Study GroupW P Witjes, M König, F P Boeminghaus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary groupS D Fosså, P H Slee, M Brausi, et al.
European Urology|January 1, 1987
Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinomaK H Kurth, F M Debruyne, R R Hall, et al.
Cell Death & Disease|July 17, 2015
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancerS-Q Liang, T M Marti, P Dorn, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 20, 2017
Virosome-bound antigen enhances DC-dependent specific CD4<sup>+</sup> T cell stimulation, inducing a Th1 and Treg profile in vitroRebecca A M Blom, Mario Amacker, Christian Moser, et al.
Theranostics|January 6, 2022
Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesotheliomaHaitang Yang, Sabina Berezowska, Patrick Dorn, et al.
Ebiomedicine|July 5, 2021
Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancerHaitang Yang, Beibei Sun, Ke Xu, et al.
Plos One|September 30, 2016
A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and VirosomesRebecca A M Blom, Silvia T Erni, Kristína Krempaská, et al.
British Journal of Urology|April 1, 1991
Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub GroupB Richards, M K Parmar, C K Anderson, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Cancers|April 3, 2021
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural MesotheliomaHaitang Yang, Sean R R Hall, Beibei Sun, et al.
European Urology|November 24, 1999
Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder. European Bropirimine Study GroupW P Witjes, M König, F P Boeminghaus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary groupS D Fosså, P H Slee, M Brausi, et al.
European Urology|January 1, 1987
Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinomaK H Kurth, F M Debruyne, R R Hall, et al.
Cell Death & Disease|July 17, 2015
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancerS-Q Liang, T M Marti, P Dorn, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 20, 2017
Virosome-bound antigen enhances DC-dependent specific CD4<sup>+</sup> T cell stimulation, inducing a Th1 and Treg profile in vitroRebecca A M Blom, Mario Amacker, Christian Moser, et al.
Theranostics|January 6, 2022
Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesotheliomaHaitang Yang, Sabina Berezowska, Patrick Dorn, et al.
Ebiomedicine|July 5, 2021
Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancerHaitang Yang, Beibei Sun, Ke Xu, et al.
Plos One|September 30, 2016
A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and VirosomesRebecca A M Blom, Silvia T Erni, Kristína Krempaská, et al.
British Journal of Urology|April 1, 1991
Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub GroupB Richards, M K Parmar, C K Anderson, et al.
Pageof 10